Signaling pathways perturbing muscle mass.
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Purpose of review To discuss the mechanisms of muscle loss during cachexia. Recent findings Cachexia can be defined as a wasting of lean body mass that cannot be reversed nutrionally, indicating a dysregulation in the pathways maintaining body composition. In skeletal muscle, during cachexia, there is an upregulation of protein degradation. A search for transcriptional markers of muscle atrophy led to the discovery of the E3 ubiquitin ligases MuRF1 and MAFbx (also called Atrogin-1). These genes are upregulated in multiple models of atrophy and cachexia. They target particular protein substrates for degradation via the ubiquitin/proteasome pathway. The insulin-like growth factor-1 can block the transcriptional upregulation of MuRF1 and MAFbx via the phosphatidylinositol-3 kinase/Akt/Foxo pathway. MuRF1's substrates include several components of the sarcomeric thick filament, including myosin heavy chain. Thus, by blocking MuRF1, insulin-like growth factor-1 prevents the breakdown of the thick filament, particularly myosin heavy chain, which is asymmetrically lost in settings of cortisol-linked skeletal muscle atrophy. Insulin-like growth factor-1/phosphatidylinositol-3 kinase/Akt signaling also dominantly inhibits the effects of myostatin, which is a member of the transforming growth factor-[beta] family of proteins. Deletion or inhibition of myostatin causes a significant increase in skeletal muscle size. Recently, myostatin has been shown to act both by inhibiting gene activ…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These two systems are controlled by a transcriptional program that upregulates several crucial and rate-limiting enzymes (Glass, 2010; Jagoe and Goldberg, 2001).”
From Proteasome dysfunction induces muscle growth defects and protein aggregation (2014) · cites this paper as Glass, 2010
Citations
Cites
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Self-citationSandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Self-citationDouble muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Self-citationFoxO3 Controls Autophagy in Skeletal Muscle In Vivo
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.001 · Cited by 1,953
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583
Self-citationA deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Research works printed but not linked: 1
- Stitt, 2004, Mol Cell, 14, 395, 10.1016/S1097-2765(04)00211-4 · DOI · Paper page
Cited by
Items 101–200 of 359
Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks
Rinaldi, F., & Perlingeiro, R. C. R. (2013) · Translational research · doi:10.1016/j.trsl.2013.11.006 · Cited by 64
Solagna, F., Tezze, C., Lindenmeyer, M. T., Lu, S. Y., Wu, G., Liu, S., Zhao, Y., Mitchell, R., Meyer, C., Omairi, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci135821 · Cited by 68
“Cachexia-induced muscle loss is generally explained by reduced protein synthesis, increased degradation, or a relative imbalance of the two (13).”
BackgroundMeneses, C., Morales, M. G., Ábrigo, J., Simón, F., Brandan, E., & Cabello‐Verrugio, C. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1617-9 · Cited by 65
COPD elicits remodeling of the diaphragm and vastus lateralis muscles in humans
Levine, S., Bashir, M. H., Clanton, T. L., Powers, S. K., & Singhal, S. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01121.2012 · Cited by 62
“Finally, despite the myostatin-induced proteolysis, the IGF-I-phosphatidylinositol 3-kinase pathway can still stimulate Akt; indeed, laboratory experiments (18, 71) have indicated that sufficiently intense stimulation of Akt by this growth pathway can overcome the effects of myostatin.”
BackgroundHanson, A. M., Harrison, B. C., Young, M. H., Stodieck, L., & Ferguson, V. L. (2012) · Muscle & Nerve · doi:10.1002/mus.23753 · Cited by 69
Olson, B., Marks, D. L., & Grossberg, A. J. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12630 · Cited by 56
“Muscle loss in cachexia owes to a combination of reduced protein synthesis and increased protein catabolism.(168) The relative influence of altered synthesis and degradation to wasting”
BackgroundBrocca, L., Longa, E., Cannavino, J., Seynnes, O., de Vito, G., McPhee, J., Narici, M., Pellegrino, M. A., & Bottinelli, R. (2015) · The Journal of Physiology · doi:10.1113/jp271188 · Cited by 58
Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in mice
Murphy, K. T., Cobani, V., Ryall, J. G., Ibebunjo, C., & Lynch, G. S. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01183.2010 · Cited by 58
“The expression of these ubiquitin ligases is elevated in numerous conditions of muscle wasting, including hindlimb casting (19), and known targets of atrogin-1 include MyoD, a muscle regulatory factor important in muscle regeneration, and eIF-3f, a translation initiation factor, whereas MuRF-1 has been shown to direct…”
BackgroundImplications of glucocorticoid therapy in idiopathic inflammatory myopathies
Hanaoka, B. Y., Peterson, C. A., Horbinski, C., & Crofford, L. J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.85 · Cited by 57
Moreau, J., Ordan, M., Barbe, C., Mazza, C., Perrier, M., Botsen, D., Brasseur, M., Portefaix, C., Renard, Y., Tallière, B., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2238 · Cited by 60
Erol, A. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.11.023 · Cited by 59
Sarcopenia in Orthopedic Surgery
Bokshan, S. L., DePasse, J. M., & Daniels, A. H. (2016) · Orthopedics · doi:10.3928/01477447-20160222-02 · Cited by 61
Drescher, C., Konishi, M., Ebner, N., & Springer, J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.033 · Cited by 53
“factors (FoxO) in muscle [40] resulting in increased proteolysis by inducing the expression of MAFbx and MuRF-1 [15].”
BackgroundSon, Y. H., Jang, E. J., Kim, Y. W., & Lee, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.002 · Cited by 60
Cella, P. S., Marinello, P. C., Borges, F. H., Ribeiro, D. F., Chimin, P., Testa, M. T. J., Guirro, P. B., Duarte, J. A., Cecchini, R., Guarnier, F. A., et al. (2020) · European Journal of Nutrition · doi:10.1007/s00394-019-01933-6 · Cited by 51
Palus, S., von Haehling, S., FLACH, V., Tschirner, A., Doehner, W., Anker, S. D., & Springer, J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.150 · Cited by 52
Liu, J., Fu, R., Liu, R., Zhao, G., Zheng, M., Cui, H., Li, Q., Song, J., Wang, J., & Wen, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159722 · Cited by 55
Muscle Wasting and Sarcopenia in Heart Failure: A Brief Overview of the Current Literature
von Haehling, S. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12388 · Cited by 51
“ubiquitin-proteasome pathway, autophagy, and apoptosis mediated by caspase signalling.(30) The human skeletal muscle”
BackgroundTreating cancer cachexia to treat cancer
Lee, S.-J., & Glass, D. J. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-2 · Cited by 50
“Loss of muscle mass can result either from primary muscle degenerative diseases, such as the muscular dystrophies, or as a secondary consequence of cachectic disease processes also affecting other tissues, such as cancer, burns, renal failure, sepsis and congestive heart failure (for review, see [1]).”
BackgroundSelf-citationmiR-18a induces myotubes atrophy by down-regulating IgfI
Liu, C., Wang, M., Chen, M., Zhang, K., Gu, L., Li, Q., Yu, Z., Li, N., & Meng, Q. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.07.020 · Cited by 51
Macciò, A., Sanna, E., Neri, M., Oppi, S., & Madeddu, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062890 · Cited by 54
“, ERK, PI3K/Akt/mTOR, and STAT-3 pathway have been associated with muscle wasting [87,88]; however, the Janus kinase (JAK)/STAT is the most well-studied pathway.”
BackgroundCarda, S., Cisari, C., & Invernizzi, M. (2013) · PubMed · Cited by 67
nNOS regulation of skeletal muscle fatigue and exercise performance
Percival, J. M. (2011) · Biophysical Reviews · doi:10.1007/s12551-011-0060-9 · Cited by 52
“FoxO3 is a pivotal transcription factor involved in the regulation of muscle mass (Glass 2010).”
BackgroundSalmerón, C., Navarro, I., Johnston, I. A., Gutiérrez, J., & Capilla, E. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1121-0 · Cited by 58
“MuRF1 is involved in the breakdown of myofibrillar proteins such as myosin heavy chain, whereas MAFbx participates in the control of protein synthesis, regulating transcription factors such as MyoD [19,20].”
BackgroundManzano, R., Toivonen, J. M., Oliván, S., Calvo, A. C., Moreno‐Igoa, M., Muñoz, M. J., Zaragoza, P., García‐Redondo, A., & Osta, R. (2011) · Neurodegenerative Diseases · doi:10.1159/000324159 · Cited by 57
“and ubiquitin-proteasome-mediated degradation of MYOD1 occurs in several models of skeletal muscle atrophy [”
BackgroundDalbo, V. J., Roberts, M. D., Sunderland, K. L., Poole, C. N., Stout, J. R., Beck, T. W., Bemben, M., & Kerksick, C. M. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr091 · Cited by 47
Degradation of skeletal muscle protein during growth and development of salmonid fish
Немова, Н. Н., Лысенко, Л. А., & Канцерова, Н. П. (2016) · Russian Journal of Developmental Biology · doi:10.1134/s1062360416040068 · Cited by 55
“For instance, the Akt-FoxO signaling pathway involved in the regulation of autophagy is functionally inactive in fish (Cleveland and Evenhuis, 2010), in contrast to the decisive role of this pathway in mammalian muscle (Glass, 2010).”
BackgroundThe histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy
Samant, S. A., Kanwal, A., Pillai, V. B., Bao, R., & Gupta, M. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-10838-5 · Cited by 46
Bansal, S., Luu, B. E., & Storey, K. B. (2015) · Journal of Comparative Physiology B · doi:10.1007/s00360-015-0951-3 · Cited by 45
“Several molecular pathways involved in the maintenance of muscle mass have been well characterized such as the PI3K/Akt pathway and MAPK signaling pathway (Glass 2005, 2010).”
Hormones, Metabolism and the Benefits of Exercise
(2017) · Research and Perspectives in Endocrine Interactions · doi:10.1007/978-3-319-72790-5 · Cited by 44
The TWEAK-Fn14 System: Breaking the Silence of Cytokine-Induced Skeletal Muscle Wasting
Bhatnagar, S., & Kumar, A. (2012) · Current Molecular Medicine · doi:10.2174/156652412798376107 · Cited by 44
“MuRF1 or MAFbx compared to wild-type in response to a wide variety of stimuli [46-48].”
BackgroundHu, S., Katz, M., Chin, S., Qi, X., Cruz, J. M., Ibebunjo, C., Zhao, S.-C., Chen, A. Y.-C., & Glass, D. J. (2012) · Science Signaling · doi:10.1126/scisignal.2002466 · Cited by 51
“This pathway functions in many cells and promotes skeletal muscle mass (13).”
BackgroundSelf-citationChen, L., Chen, L., Wan, L., Huo, Y., Huang, J., Li, J., Lu, J., Xin, B., Yang, Q., & Guo, C. (2019) · Oncology Reports · doi:10.3892/or.2019.7205 · Cited by 63
“Two E3 ubiquitin ligases, muscle RING‐finger containing protein‐1 (MuRF1) and muscle atrophy F box protein (MAFbx), are specifically expressed in atrophying skeletal muscle and mediate the degradation of muscle protein (13,14).”
BackgroundFaure, C., Morio, B., Chafey, P., Plénier, S. L., Noirez, P., Randrianarison-Huetz, V., Cynober, L., Aussel, C., & Moinard, C. (2013) · PROTEOMICS · doi:10.1002/pmic.201200262 · Cited by 49
“Both MuRF1 and MAFbx encode for components of the ubiquitin-proteasome pathway [31].”
BackgroundTargeted ablation of p38α MAPK suppresses denervation-induced muscle atrophy
Yuasa, K., Okubo, K., Yoda, M., Otsu, K., Ishii, Y., Nakamura, M., Itoh, Y., & Horiuchi, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-26632-w · Cited by 43
Muscle wasting: an overview of recent developments in basic research
Palus, S., von Haehling, S., & Springer, J. (2014) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-014-0157-7 · Cited by 41
“Among others, the glucocorticoid receptor activates REDD1 and KLF15 expression, both inhibiting mTOR activity, KLF15 via BCAT2 gene activation, and it also directly upregulates the expression of MuRF-1 and MAFbx resulting in atrophy [33].”
BackgroundAndrés‐Mateos, E., Mejías, R., Soleimani, A. A., Lin, B. M., Burks, T. N., Marx, R., Lin, B., Zellars, R. C., Zhang, Y., Huso, D. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048884 · Cited by 42
Seiliez, I., Taty, G. C. T., Bugeon, J., Dias, K., Sabin, N., & Gabillard, J. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.02.008 · Cited by 42
“These two proteins have been shown to play a central role in mediating the Ub–Proteasomal depende nt muscle wasting in response to atrophic stimuli (Glass, 2010).”
BackgroundGraça, F. A., Rai, M., Hunt, L. C., Stephan, A., Wang, Y., Gordon, B., Wang, R., Quarato, G., Xu, B., Fan, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30120-1 · Cited by 43
Busanello, A., Battistelli, C., Carbone, M., Mostocotto, C., & Maione, R. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks619 · Cited by 44
Cobalt triggers necrotic cell death and atrophy in skeletal C2C12 myotubes
Rovetta, F., Stacchiotti, A., Faggi, F., Catalani, S., Apostoli, P., Fanzani, A., & Aleo, M. F. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.05.005 · Cited by 43
“…account for the transcriptional up-regulation of different atrogenes (Atrogin-1, MuRF1 and Bnip3) and activation of the proteasome and autophagy systems, leading to atrophy (Cai et al., 2004; Cao et al., 2005; Foletta et al., 2011; Glass, 2010; Li et al., 2008; Sandri, 2010; Sandri et al., 2004).”
BackgroundNandrolone Normalizes Determinants of Muscle Mass and Fiber Type after Spinal Cord Injury
Wu, Y., Zhao, J., Zhao, W., Pan, J., Bauman, W. A., & Cardozo, C. P. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.2203 · Cited by 42
“Conversely, muscle anabolism is stimulated by IGF-1, which inactivates FOXO1 and FOXO3A and blocks atrophy-related increases in the expression of MAFbx and MuRF1 (Stitt et al., 2004).”
BackgroundInfluentialTajrishi, M. M., Shin, J. S., Hetman, M., & Kumar, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568626 · Cited by 44
Graham, Z., Collier, L., Peng, Y., Sáez, J. C., Bauman, W. A., Qin, W., & Cardozo, C. P. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2015.4058 · Cited by 40
“10 Although considerable progress has been made toward understanding the molecular mechanisms that underlie muscle atrophy resulting from SCI, or to other conditions of immobilization or paralysis, 11,12 they remain incompletely understood.”
Salvini, T. F., Durigan, J. L. Q., Peviani, S. M., & Russo, T. L. (2012) · Brazilian Journal of Physical Therapy · doi:10.1590/s1413-35552012005000027 · Cited by 40
Lee, S.-J., Bae, J. H., Lee, H., Lee, H., Park, J., Kang, J.-S., & Bae, G.-U. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112054 · Cited by 38
Gastric cancer does not affect the expression of atrophy-related genes in human skeletal muscle
D’Orlando, C., Marzetti, E., François, S., Lorenzi, M., Conti, V., Stasio, E. D., Rosa, F., Brunelli, S., Doglietto, G. B., Pacelli, F., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.23945 · Cited by 44
“The pathophysiology of CC is characterized by a negative protein and energy balance sustained by the combination of reduced food intake and abnormal metabolism.(3) Although increased protein breakdown probably plays an important role in the loss of muscle mass among cancer patients, the involvement and relative import…”
An, C.-I., Ganio, E. A., & Hagiwara, N. (2013) · Skeletal Muscle · doi:10.1186/2044-5040-3-11 · Cited by 45
“GST in addition to its well-established roles in muscle atrophy [15].”
BackgroundDutt, V., Saini, V., Gupta, P., Kaur, N., Bala, M., Gujar, R., Grewal, A., Gupta, S. K., Dua, A., & Mittal, A. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.12.015 · Cited by 39
Atteinte musculaire et glucocorticoïdes
Perrot, S., & Jeunne, C. L. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.01.004 · Cited by 37
Mechanisms for maintaining muscle
Banerjee, A., & Guttridge, D. C. (2012) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e328359b681 · Cited by 40
Sensitive, Robust, and Cost-Effective Approach for Tyrosine Phosphoproteome Analysis
Dong, M., Bian, Y., Wang, Y., Dong, J., Yao, Y., Deng, Z., Qin, H., Zou, H., & Ye, M. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b02078 · Cited by 35
Zeitz, J. O., Käding, S.-C., Niewalda, I. R., Most, E., Dorigam, J. C. D. P., & Eder, K. (2019) · Poultry Science · doi:10.3382/ps/pez396 · Cited by 41
“The FOXO1 transcription factor, which induces protein degradation by increasing the expression of TRIM63 [also called Muscle RING-finger protein-1 (MURF1)] and FBXO32 (also called atrogin1) involved in the UPS pathway, and which is required for autophagy induction, is inactivated due to phosphorylation by Akt (Glass,…”
BackgroundOhsawa, Y., Okada, T., Nishimatsu, S., Ishizaki, M., Suga, T., Fujino, M., Murakami, T., Uchino, M., Tsuchida, K., Noji, S., et al. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.78 · Cited by 38
Effects of methionine on muscle protein synthesis and degradation pathways in broilers
Zeitz, J. O., Mohrmann, S., Käding, S.-C., Devlikamov, M., Niewalda, I. R., Whelan, R., Helmbrecht, A., & Eder, K. (2018) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13026 · Cited by 40
Ethanol Does Not Delay Muscle Recovery but Decreases Testosterone/Cortisol Ratio
Haugvad, A., Haugvad, L., Hamarsland, H., & Paulsen, G. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000339 · Cited by 40
IUGR impairs cardiomyocyte growth and maturation in fetal sheep
Jonker, S. S., Kamna, D., LoTurco, D., Kailey, J. M., & Brown, L. D. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0382 · Cited by 35
Hibernation: The search for treatments to prevent disuse-induced skeletal muscle atrophy
Bodine, S. C. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.06.003 · Cited by 39
“MuRF1 andMAFbx have ubiquitin ligase activity and putative substrates have been identified (Glass, 2010); although, the list of substrates is likely incomplete and further in vivo validation of those substrates identified using in vitro assays is required.”
BackgroundMuscle–bone interactions: movement in the field of mechano–humoral coupling of muscle and bone
Cardozo, C. P., & Graham, Z. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13411 · Cited by 32
Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure
Bielecka-Dabrowa, A. M., Fabiś, J., Mikhailidis, D. P., von Haehling, S., Sahebkar, A., Rysz, J., & Banach, M. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.003 · Cited by 31
Alterations of cAMP-dependent signaling in dystrophic skeletal muscle
Rudolf, R., Khan, M. M., Lustrino, D., Labeit, S., Kettelhut, Í. D. C., & Navegantes, L. C. C. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00290 · Cited by 37
“It is, thus, not only driving locomotion but also represents a major metabolic organ due to its enormous energy expenditure, its capability to take up glucose in an insulin-dependent manner, and its role as amino acid-source during catabolic conditions (Sandri, 2008; Glass, 2010).”
BackgroundFoxOs in neural stem cell fate decision
Ro, S.-H., Liu, D., Yeo, H., & Paik, J.-H. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.07.017 · Cited by 33
TLR2 deficiency attenuates skeletal muscle atrophy in mice
Kim, D., Cha, H.-N., Jo, H. J., Song, I., Baek, S., Dan, J., Kim, Y.-W., Kim, J., Lee, I., Seo, J., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.144 · Cited by 32
Dexamethasone downregulates caveolin-1 causing muscle atrophy via inhibited insulin signaling
Son, Y. H., Lee, S.-J., Lee, K. B., Lee, J.-H., Jeong, E. M., Chung, S. G., Park, S.-C., & Kim, I.-G. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0490 · Cited by 33
“2008), andtheexpression levels of MAFbx/Atrogin1, MuRF1, Cav1, and Gapdh mRNA were assessed by real-time RT-PCR using an iCycler RT-PCR instrument (Bio-Rad).”
BackgroundInfluentialNeurohr, J. M., Paulson, E. T., & Kinsey, S. T. (2021) · Journal of Experimental Biology · doi:10.1242/jeb.242462 · Cited by 32
MacLea, K. S., Abuhagr, A. M., Pitts, N. L., Covi, J. A., Bader, B. D., Chang, E. S., & Mykles, D. L. (2012) · Journal of Experimental Biology · doi:10.1242/jeb.062869 · Cited by 36
“In mammals, Mstn represses protein synthesis by inhibiting the metazoan target of rapamycin (mTOR) (reviewed by Drummond et al., 2009a; Glass, 2010; Matsakas and Patel, 2009a; McCarthy and Esser, 2010; Otto and Patel, 2010). mTOR is a serine/theonine protein kinase that associates with Rheb (Ras…”
BackgroundInfluentialBenavides-Rodriguez, L. E., García‐Hermoso, A., Rodrigues-Bezerra, D., Izquierdo, M., Correa‐Bautista, J. E., & Ramírez‐Vélez, R. (2017) · Nutrients · doi:10.3390/nu9070695 · Cited by 40
“[42] reported that IL-6 and TNF-α were related positively to fat mass and negatively to muscle mass, participating actively in the development of sarcopenia [43,44] by provoking an involuntary loss of muscle mass without initial weight loss.”
BackgroundMechanotransduction pathways in skeletal muscle hypertrophy
Yamada, A. K., Verlengia, R., & Bueno Junior, C. R. (2012) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2011.641978 · Cited by 31
“Skeletal muscle mass is regulated by complex molecular systems that have only recently been determined (1).”
BackgroundCassolla, P., Moreira, C. C. L., Liboni, T. F., Zaia, C. T. B. V., Borba‐Murad, G. R., Bazotte, R. B., & de Souza, H. M. (2011) · Cell Biochemistry and Function · doi:10.1002/cbf.2792 · Cited by 31
Jiang, H., & Ge, X. (2013) · Journal of Animal Science · doi:10.2527/jas.2013-7095 · Cited by 36
Pituitary pars intermedia dysfunction does not necessarily impair insulin sensitivity in old horses
Mastro, L. M., Adams, A. A., & Urschel, K. L. (2014) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2014.07.003 · Cited by 32
“The signaling pathways associated with both protein accretion and breakdown are affected by insulin [12,13], as well as other anabolic signals including amino acids and exercise [12,14].”
BackgroundGaining insight into the role of FoxO1 in the progression of disuse-induced skeletal muscle atrophy
Vilchinskaya, N. A., Altaeva, E. G., & Lomonosova, Y. N. (2022) · Advances in Biological Regulation · doi:10.1016/j.jbior.2022.100903 · Cited by 34
Hnia, K., Kretz, C., Amoasii, L., Böhm, J., Liu, X., Messaddeq, N., Qu, C., & Laporte, J. (2011) · Advances in Biological Regulation · doi:10.1016/j.advenzreg.2011.09.007 · Cited by 32
Paco, S., Kalko, S. G., Jou, C., Rodríguez, M. A., Corbera, J., Muntoni, F., Feng, L., Rivas, E., Torner, F., Gualandi, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077430 · Cited by 32
“regulating regeneration and size of the muscle fibre [44].”
BackgroundRosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia
Trobec, K. Č., Palus, S., Tschirner, A., von Haehling, S., Doehner, W., Lainščak, M., Anker, S. D., & Springer, J. (2013) · Nutrition · doi:10.1016/j.nut.2013.12.005 · Cited by 31
Muscle wasting: An overview of recent developments in basic research
Palus, S., von Haehling, S., & Springer, J. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.086 · Cited by 30
Flaherty, S. E., Song, L., Albuquerque, B., Rinaldi, A., Piper, M. E., Hirenallur-Shanthappa, D. K., Chen, X., Stansfield, J. C., Asano, S. M., Pashos, E. E., et al. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13715 · Cited by 33
“These pathways are activated coordinately by transcription factors of the Foxo family [29–31] and NF-kappaB family [32, 33].”
STEINER, M. C., Roubenoff, R., Tal‐Singer, R., & Polkey, M. I. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-201765 · Cited by 30
das Neves, W., Alves, C. R. R., de Almeida, N. R., Guimarães, F. L. R., Ramires, P. R., Brum, P. C., & Lancha, A. H. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.08.025 · Cited by 31
“Skeletal muscle wasting is attributed to a complex interplay between protein synthesis and degradation pathways [22, 26, 27, 33].”
Li, B., Wan, L., Li, Y., Yu, Q., Chen, P., Gan, R., Yang, Q., Han, Y., & Guo, C. (2014) · Tumor Biology · doi:10.1007/s13277-014-2558-9 · Cited by 28
“Cancer cachexia largely causes skeletal muscle mass loss that is generally due to an imbalance between anabolism and catabolism resulting from reduced protein synthesis and increased degradation [14].”
BackgroundThe Role of Cullin-RING Ligases in Striated Muscle Development, Function, and Disease
Blondelle, J., Biju, A., & Lange, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217936 · Cited by 28
Rivas, D. A., Peng, F., Benard, T., da Silva, A. S. R., Fielding, R. A., & Margolis, L. M. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00190.2021 · Cited by 31
Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1
He, Z., Song, Q., Yu, Y., Liu, F., Zhao, J., Waikeong, U., Da, X., Xu, C., Yao, Y., & Wang, Q. K. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13179 · Cited by 27
“Muscle atrophy is inhibited in mice null for MuRF1 or MAFbx, suggesting that these ubiquitin ligases are the master drivers of muscle proteolysis.(38) Consistent with these findings, our study suggests that one of the mechanisms by which AGGF1 inhibits degradation of muscle proteins is through the re-”
Madeddu, C., Mantovani, G., Gramignano, G., Astara, G., & Macciò, A. (2015) · Future Oncology · doi:10.2217/fon.15.195 · Cited by 27
“69 Glass DJ. Signaling pathways perturbing muscle mass. Curr. Opin. Clin. Nutr. Metab. Care 13, 225–229 (2010).”
Parry, S. M., Chapple, L. S., & Mourtzakis, M. (2018) · Nutrition in Clinical Practice · doi:10.1002/ncp.10213 · Cited by 27
Regulation of SETD7 Methyltransferase by SENP3 Is Crucial for Sarcomere Organization and Cachexia
Nayak, A., Dávila, A. J. L., Kefalakes, E., Holler, T., Kraft, T., & Amrute‐Nayak, M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.107 · Cited by 27
Therapeutic considerations of sarcopenia in heart failure patients
Saitoh, M., Ebner, N., von Haehling, S., Anker, S. D., & Springer, J. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1424542 · Cited by 30
“described, including the ubiquitin-proteasome system (UPS), apoptosis, and autophagy [52].”
BackgroundAtrogin1-induced loss of aquaporin 4 in myocytes leads to skeletal muscle atrophy
Chung, S. W., Kim, J.-Y., Yoon, J. P., Suh, D. W., Yeo, W. J., & Lee, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-71167-8 · Cited by 29
Schisandrae Fructus Supplementation Ameliorates Sciatic Neurectomy-Induced Muscle Atrophy in Mice
Kim, J. W., Ku, S., Kim, K. Y., Kim, S. G., Han, M. H., Kim, G., Hwang, H. J., Kim, B. W., Kim, C. M., & Choi, Y. H. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/872428 · Cited by 26
“It is well established that the serum levels of proinflammatory cytokines, particularly IL-1β and TNF-α, are elevated in cachectic patients contributing to muscle atrophy [4, 8, 9].”
BackgroundInfluentialSeiliez, I., Vélez, E. J., Lutfi, E., Dias, K., Plagnes‐Juan, E., Marandel, L., Panserat, S., Geurden, I., & Cassy, S. (2017) · Aquaculture · doi:10.1016/j.aquaculture.2017.01.010 · Cited by 28
Li, Y., Zhang, F., Modrak, S., Little, A., & Zhang, H. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14221 · Cited by 27
“Suppressed protein synthesis and enhanced protein degradation play the major roles in CACassociated skeletal muscle loss (Glass, 2010, Smith and Tisdale, 1993, Argiles et al., 2014).”
BackgroundChemotherapy triggers cachexia by deregulating synergetic function of histone‐modifying enzymes
Amrute‐Nayak, M., Pegoli, G., Holler, T., Dávila, A. J. L., Lanzuolo, C., & Nayak, A. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12645 · Cited by 22
“Thus, in addition to cancer‐induced cachexia, chemotherapy‐induced cachexia exacerbates the condition, leading to profound loss of muscle mass and function.(16) Che-”
BackgroundThe role of extracellular vesicles in skeletal muscle wasting
Zhang, X., Zhao, Y., & Yan, W. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13364 · Cited by 25
“26 Autophagy genes can also be activated through signalling cascades of these cytokines.”
BackgroundSkeletal muscle myogenesis is regulated by G protein-coupled receptor kinase 2
García‐Guerra, L., Vila‐Bedmar, R., Carrasco‐Rando, M., Cruces‐Sande, M., Martín, M., Ruiz‐Gómez, A., Ruiz‐Gómez, M., Lorenzo, M., Fernández‐Veledo, S., Mayor, F., et al. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju025 · Cited by 26
“Their inhibition blocks myogenesis (Glass, 2010a) as so happens with Akt, an important downstream target of PI3-K (Fujio et al., 1999; Jiang et al., 1999; Conejo and Lorenzo, 2001). p38MAPK is also a central player in this process (Conejo et al., 2002; Perdiguero et al., 2007a) acting through…”
BackgroundLim, J., Lee, Y. J., Cho, H.-R., Park, D., Jung, G., Ku, S., & Choi, J. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3251 · Cited by 28
“Protein synthesis is activated by the insulin‐like growth factor 1 (IGF‐1)/PI3K/Akt pathway (6,70).”
BackgroundAcute uremia suppresses leucine-induced signal transduction in skeletal muscle
McIntire, K. L., Chen, Y., Sood, S., & Rabkin, R. (2013) · Kidney International · doi:10.1038/ki.2013.216 · Cited by 24
Bae, S.-K., Cha, H.-N., Ju, T.-J., Kim, Y., Kim, H. S., Kim, Y., Dan, J., Kim, J., Kim, S.-D., & Park, S. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00431.2011 · Cited by 24
“For the ubiquitination of protein, the coordinated reaction of three sets of enzymes, ubiquitin-activating enzyme (E1), ubiqutin-conjugating enzyme (E2), and ubiqutin ligases (E3), are required, and the key enzymes in this process are E3 ubiquitin ligases, which functions as the protein recognition component (16, 52).”
Intermittent bout exercise training down-regulates age-associated inflammation in skeletal muscles
Kim, J., & Yi, H. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.11.001 · Cited by 26
“The mTOR signaling in muscle growth and hypertrophy is relatively well understood, and the mechanisms are largely similar to those in cell growth regulation (Ge and Chen, 2012; Glass, 2010).”
BackgroundZeitz, J. O., Käding, S.-C., Niewalda, I. R., Machander, V., Dorigam, J. C. D. P., & Eder, K. (2019) · Archives of Animal Nutrition · doi:10.1080/1745039x.2019.1583519 · Cited by 25
Role of Protein Arginine Methyltransferases and Inflammation in Muscle Pathophysiology
So, H.-K., Kim, S., Kang, J., & Lee, S.-J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.712389 · Cited by 26
“Activated Smad2/3 and p38MAPK are implicated in protein degradation in muscle cells via induction of Muscle RING-finger containing protein-1 (MuRF1) and Atrogin-1, two major musclespecific E3 ubiquitin ligases (Glass, 2010) that are bonafide markers of muscle atrophy phenotype (Bodine et al., 2001).”
Background
Metadata
- Authors
- Glass, D. J.
- Corresponding author
- Glass, David J
- ORCID
- Glass, David J
- Venue
- Current Opinion in Clinical Nutrition and Metabolic Care
- Published
- 2010-05
- Volume
- 13
- Issue
- 3
- Pages
- 225-229
- ISSN
- 1363-1950 (ISSN-L)
- OpenAlex
- W2078192607
- Cited by
- 359
- References
- 56
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 17 · 2023: 9 · 2022: 17 · 2021: 13 · 2020: 15 · 2019: 14 · 2018: 25 · 2017: 20 · 2016: 13 · 2015: 30 · 2014: 28 · 2013: 45 · 2012: 55
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Clinical Nutrition & Metabolic Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- cachexia, skeletal muscle atrophy, muscle mass loss, MuRF1, atrogin-1, ubiquitin-proteasome system, protein degradation, insulin-like growth factor I, phosphatidylinositol 3-kinase/Akt signaling, FOXO, myostatin, TGF-beta, myosin heavy chain, cortisol, lean body mass
- MeSH terms
- Forkhead Box Protein O1, Cachexia, Gene Expression Regulation, Hydrocortisone, Muscle Proteins, Muscular Atrophy, Organ Size, Signal Transduction, Transforming Growth Factor beta, Muscle, Skeletal, Myosin Heavy Chains, Phosphatidylinositol 3-Kinases, Ubiquitin-Protein Ligases, Proto-Oncogene Proteins c-akt, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.